An Herbal Derivative as the Basis for a New Approach to Treating Post-Traumatic Osteoarthritis
Technical Report,01 Sep 2016,31 Aug 2017
Harvard University Boston United States
Pagination or Media Count:
Osteoarthritis OA is a painful disease that causes the progressive destruction of joint structures, and is the most common cause of disability among military service members who are removed from active duty for medical reasons. In preliminary work with a small number of animals, we have found that the natural product derivative halofuginone HF shows promise with respect to reducing cartilage damage in the destabilized medial meniscus DMM mouse model of PTOA. HF inhibits glutamyl-prolyl-tRNA synthetase EPRS, the enzyme responsible for charging tRNAs with the amino acid proline. The goal of this grant is to test the hypothesis that EPRS inhibitors will provide the basis for a new therapeutic strategy for PTOA. We report here 1 Data demonstrating that the EPRS inhibitors HF and its less toxic derivative HFol, are effective as therapeutics for PTOA in mice, using the DMM model 2 Detailed immunohistochemical data examining the effect of HFHfol on effectors of OA 3 A new ex vivo assay using intact joint cartilage to test ex vivo efficacy of EPRS inhibitors as therapeutics for OA.
- Medicine and Medical Research